Goldman Sachs’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.5B | Buy |
|
|||||
2025
Q1 | $1.41B | Buy |
|
|||||
2024
Q4 | $1.15B | Sell |
|
|||||
2024
Q3 | $1.11B | Sell |
|
|||||
2024
Q2 | $1.03B | Sell |
|
|||||
2024
Q1 | $1B | Sell |
|
|||||
2023
Q4 | $926M | Sell |
|
|||||
2023
Q3 | $877M | Sell |
|
|||||
2023
Q2 | $1.02B | Buy |
|
|||||
2023
Q1 | $894M | Sell |
|
|||||
2022
Q4 | $831M | Sell |
|
|||||
2022
Q3 | $754M | Buy |
|
|||||
2022
Q2 | $537M | Sell |
|
|||||
2022
Q1 | $790M | Sell |
|
|||||
2021
Q4 | $805M | Buy |
|
|||||
2021
Q3 | $707M | Buy |
|
|||||
2021
Q2 | $659M | Sell |
|
|||||
2021
Q1 | $641M | Buy |
|
|||||
2020
Q4 | $526M | Buy |
|
|||||
2020
Q3 | $497M | Sell |
|
|||||
2020
Q2 | $497M | Buy |
|
|||||
2020
Q1 | $456M | Sell |
|
|||||
2019
Q4 | $663M | Buy |
|
|||||
2019
Q3 | $543M | Buy |
|
|||||
2019
Q2 | $549M | Buy |
|
|||||
2019
Q1 | $473M | Sell |
|
|||||
2018
Q4 | $490M | Sell |
|
|||||
2018
Q3 | $606M | Sell |
|
|||||
2018
Q2 | $672M | Buy |
|
|||||
2018
Q1 | $514M | Buy |
|
|||||
2017
Q4 | $314M | Buy |
|
|||||
2017
Q3 | $246M | Buy |
|
|||||
2017
Q2 | $203M | Buy |
|
|||||
2017
Q1 | $139M | Buy |
|
|||||
2016
Q4 | $115M | Sell |
|
|||||
2016
Q3 | $134M | Sell |
|
|||||
2016
Q2 | $154M | Buy |
|
|||||
2016
Q1 | $68.2M | Sell |
|
|||||
2015
Q4 | $89.5M | Buy |
|
|||||
2015
Q3 | $32.6M | Sell |
|
|||||
2015
Q2 | $87.1M | Buy |
|
|||||
2015
Q1 | $61.3M | Sell |
|
|||||
2014
Q4 | $77M | Buy |
|
|||||
2014
Q3 | $40.6M | Sell |
|
|||||
2014
Q2 | $81.4M | Buy |
|
|||||
2014
Q1 | $80.9M | Sell |
|
|||||
2013
Q4 | $208M | Sell |
|
|||||
2013
Q3 | $241M | Sell |
|
|||||
2013
Q2 | $197M | Buy |
|